Clinical significance of specific autoantibodies in juvenile dermatomyositis

Journal of Rheumatology

Volumn 23, Issue 10, 1996, Pages 1794-1797

  Feldman, Brian M ^a,b   Reichlin, Morris ^d   Laxer, Ronald M ^a   Targoff, Ira N ^d   Stein, Leonard D ^c   Silverman, Earl D ^b  

^a Division of Rheumatology   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

adolescence; antibody specific; autoantibodies; child; dermatomyositis; myositis

Indexed keywords

ANTIBODY; AUTOANTIBODY; MYOSITIS ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADOLESCENT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BIOPSY; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; HUMANS; INFANT; MALE; POLYMYOSITIS; SEVERITY OF ILLNESS INDEX;

EID: 0029844142     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
2. Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-1.
3. Miller FW: Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies [Grand Rounds of the Clinical Center, NIH, Bethesda, MD]. JAMA 1993;270:1846-9.
4. Love LA, Leff RL, Fraser DD, et al.: A new approach to the classification of idiopathic inflammatory myopathy: Myositisspecific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360-74.
5. Pachman LM, Friedman JM, Maryjowski-Sweeney ML, et al.: Immunogenetic studies of juvenile dermatomyositis. III. Study of antibody to organ-specific and nuclear antigens. Arthritis Rheum 1985;28:151-7.
6. Montecucco C, Ravelli A, Caporali R, et al.: Autoantibodies in juvenile dermatomyositis. Clin Exp Rheumatol 1990;8:193-6.
7. Rider LG, Miller FW, Targoff IN, et al.: A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis Rheum 1994;11:1534-8.
8. Corey M, McLaughlin F, Williams M, Levison H: A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-91.
9. Reichlin M, Arnett FC Jr: Multiplicity of antibodies in myositis sera. Arthritis Rheum 1984;27:1150-6.
10. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F: The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992;35:498-502.
11. Feldman BM, Ayling-Campos A, Luy L, Stevens D, Silverman ED, Laxer RM: Measuring disability in juvenile dermatomyositis: Validity of the childhood health assessment questionnaire. J Rheumatol 1995;22:326-31.
12. Walker FJ, Jeffrey PD, Webb J, Tymms KE: Polydermatomyositis with anti-PL7 antibody: Clinical and laboratory follow-up over a five year period. Clin Exp Rheumatol 1989;7:537-40.
13. Cambridge G, Ovadia E, Isenberg DA, Dubowitz V, Sperling J, Sperling R: Juvenile dermatomyositis: Serial studies of circulating autoantibodies to a 56kD nuclear protein. Clin Exp Rheumatol 1994;12:451-7.
14. Blaszczyk M, Jablonska S, Szymanska-Jagiello W, Jarzabek-Chorzelska M, Chorzelski T, Mohamed AH: Childhood scleromyositis: An overlap syndrome associated with PM-Scl antibody. Pediatr Dermatol 1991;8:1-8.